Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Magellan Health Inc    MGLN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

MAGELLAN HEALTH INC : Entry into a Material Definitive Agreement (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/10/2017 | 10:21pm CET

Item 1.01. Entry into a Material Definitive Agreement

On January 10, 2017, Magellan Health, Inc. (the "Company") entered into a Credit Agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., Citigroup Global Markets Inc., Compass Bank (d/b/a BBVA Compass), JPMorgan Chase Bank, N.A., Suntrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC as joint lead arrangers and joint bookrunners, that provides for a $200.0 million delayed draw term loan to Magellan Pharmacy Services, Inc., a wholly-owned subsidiary of the Company, as the borrower (the "2017 Credit Facility").

The 2017 Credit Facility is guaranteed by substantially all of the non-regulated subsidiaries of the Company and will mature on December 29, 2017. The proceeds of the 2017 Credit Facility will be used for working capital and general corporate purposes, including the funding of acquisitions not prohibited thereunder.

Under the 2017 Credit Facility, the annual interest rate on the term loan borrowing is equal to (i) in the case of base rate loans, the sum of an initial borrowing margin of 0.625 percent plus the higher of the prime rate, one-half of one percent in excess of the overnight "federal funds" rate, or the Eurodollar rate for one month plus 1.00 percent, or (ii) in the case of Eurodollar rate loans, the sum of an initial borrowing margin of 1.625 percent plus the Eurodollar rate for the selected interest period. The borrowing margin is subject to adjustment based on the leverage ratio of the Company. The Company, through Magellan Pharmacy Services, Inc., has the option to borrow in base rate loans or Eurodollar rate loans at its discretion. The commitment commission on the 2017 Credit Facility is 0.25 percent of the unused commitment, which rate shall be adjusted from time to time based on the Company's total leverage ratio.

The 2017 Credit Facility contains certain affirmative and negative covenants and certain events of default customary for facilities of this type and substantially identical to those applicable to the $200.0 million Credit Agreement dated June 27, 2016 which the Company, through Magellan Pharmacy Services, Inc., as borrower, entered into with various lenders (the "2016 Credit Facility"). A copy of the 2016 Credit Facility was attached as an exhibit to the Company's 10-Q Quarterly Report for the period ending June 30, 2016, which was filed with the SEC on July 29, 2016. The 2016 Credit Facility remains in effect.

The foregoing does not constitute a complete summary of the terms of the 2017 Credit Facility.

                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MAGELLAN HEALTH INC
01/10 MAGELLAN HEALTH INC : Entry into a Material Definitive Agreement (form 8-K)
01/07 MAGELLAN HEALTH : Provides Free Counseling Services and Resources to Individuals..
2016 MAGELLAN HEALTH,INC. (NASDAQ : MGLN) Files An 8-K Other Events
2016 MAGELLAN HEALTH INC : Other Events (form 8-K)
2016 MAGELLAN HEALTH,INC. (NASDAQ : MGLN) Files An 8-K Other Events
2016 MAGELLAN HEALTH INC : Other Events (form 8-K)
2016 MAGELLAN HEALTH : to Acquire Veridicus Holdings, LLC
2016 MAGELLAN HEALTH : Provides 2017 Financial Guidance
2016 MAGELLAN HEALTH : Provides Free Counseling Services and Resources to Individuals..
2016 MAGELLAN HEALTH,INC. (NASDAQ : MGLN) Files An 8-K Results of Operations and Fina..
More news
Sector news : Managed Healthcare - NEC
09:23pDJANTHEM : Ends Preauthorization for Medication to Treat Opioid Addiction
01/18DJLower Oil Prices Drag on Energy Stocks
01/18DJMore Women Are Winning CEO Job -- WSJ
01/18DJUNITEDHEALTH : Says ACA Drag Is Easing -- WSJ
01/17DJWomen Make Gains Toward Winning CEO Job
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
2016 Magellan Health closes Veridicus transaction
2016 They're Definitely High On Something
2016 Magellan sees non-GAAP earnings as high as $145M in 2017; shares down a fract..
2016 Magellan Health buys PBM outfit Veridicus Holdings for $74.5M
2016 Magellan Health Services' (MGLN) CEO Barry Smith on Q3 2016 Results - Earning..
Advertisement
Financials ($)
Sales 2016 4 907 M
EBIT 2016 175 M
Net income 2016 72,2 M
Debt 2016 309 M
Yield 2016 -
P/E ratio 2016 23,36
P/E ratio 2017 17,71
EV / Sales 2016 0,42x
EV / Sales 2017 0,28x
Capitalization 1 769 M
More Financials
Chart MAGELLAN HEALTH INC
Duration : Period :
Magellan Health Inc Technical Analysis Chart | MGLN | US5590792074 | 4-Traders
Full-screen chart
Technical analysis trends MAGELLAN HEALTH INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 78,0 $
Spread / Average Target 2,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Barry M. Smith Chairman & Chief Executive Officer
Jonathan N. Rubin Chief Financial Officer & Executive Vice President
Gary D. Anderson Chief Information Officer
Karen Amstutz Chief Medical Officer
Srinivas Koushik Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MAGELLAN HEALTH INC1.13%1 769
UNITEDHEALTH GROUP INC-1.44%150 139
AETNA INC-2.45%42 448
ANTHEM INC2.40%38 783
CIGNA CORPORATION6.43%36 449
HUMANA INC1.02%30 731
More Results